Jonathan R A Duckett1, Maya Basu. 1. Medway Maritime Hospital, Windmill Road, Gillingham, Kent, ME7 5NY, UK. jraduckett@hotmail.com
Abstract
INTRODUCTION: Although transobturator tapes (TOT) have been suggested to be equivalent to retropubic tension-free vaginal tapes (TVT) in the management of urodynamic stress incontinence, there is very little evidence for their use in women with mixed incontinence. The aim of this study was to evaluate the efficacy of the TOT against the retropubic TVT in women with mixed incontinence. PATIENTS AND METHODS: A case controlled study was used with 34 women matched for age and type of procedure. RESULTS: Ten out of 34 (29.4%) patients in the TOT group required a repeat continence procedure versus 0/34 (0%) in the retropubic group. Patients who had undergone a TOT were significantly more likely to require repeat surgery (odds ratio 10.1, 95% confidence interval 2.6-38.2). CONCLUSIONS: This study suggests a higher failure rate in women undergoing a TOT for USI and DO compared to a retropubic TVT when assessed with a case controlled study.
INTRODUCTION: Although transobturator tapes (TOT) have been suggested to be equivalent to retropubic tension-free vaginal tapes (TVT) in the management of urodynamic stress incontinence, there is very little evidence for their use in women with mixed incontinence. The aim of this study was to evaluate the efficacy of the TOT against the retropubic TVT in women with mixed incontinence. PATIENTS AND METHODS: A case controlled study was used with 34 women matched for age and type of procedure. RESULTS: Ten out of 34 (29.4%) patients in the TOT group required a repeat continence procedure versus 0/34 (0%) in the retropubic group. Patients who had undergone a TOT were significantly more likely to require repeat surgery (odds ratio 10.1, 95% confidence interval 2.6-38.2). CONCLUSIONS: This study suggests a higher failure rate in women undergoing a TOT for USI and DO compared to a retropubic TVT when assessed with a case controlled study.
Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein Journal: Neurourol Urodyn Date: 2002 Impact factor: 2.696
Authors: Linda Brubaker; Anne Stoddard; Holly Richter; Philippe Zimmern; Pamela Moalli; Stephen R Kraus; Peggy Norton; Emily Lukacz; Larry Sirls; Harry Johnson Journal: Neurourol Urodyn Date: 2009 Impact factor: 2.696